AN INDIVIDUALISED DECISION MAKING TOOL FOR USE OF LOW VERSUS STANDARD DOSE ALTEPLASE IN ACUTE ISCHAEMIC STROKE

被引：0
|
作者：
Wang, X. [1 ]
Anderson, C. [2 ]
Moullaali, T. [2 ]
Woodward, M. [3 ]
机构：
[1] NMH, George Inst Global Hlth, Sydney, NSW, Australia
[2] George Inst Global Hlth, Neurol & Mental Hlth, Sydney, NSW, Australia
[3] George Inst Global Hlth, Profess Unit, Sydney, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF STROKE | 2018年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
046
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [21] Low-dose versus standard-dose alteplase for intravenous thrombolysis in patients with acute ischemic stroke in Iran: Results from the safe implementation of treatments in stroke registry
    Sadeghi-Hokmabadi, Elyar
    Ghoreishi, Abdoreza
    Rikhtegar, Reza
    Sariaslani, Payam
    Rafie, Shahram
    Vakilian, Alireza
    Sharifipour, Ehsan
    Mehrpour, Masoud
    Saadatnia, Mohammad
    Mirza-Aghazadeh-Attari, Mohammad
    Farhoudi, Mehdi
    CURRENT JOURNAL OF NEUROLOGY, 2021, 20 (04): : 208 - 213
  • [22] Effects of Age and Ethnicity on the Benefits and Risks of Low- versus Standard-dose Alteplase in Acute Ischemic Stroke Patients: The Enchanted Trial
    Wang, Xia
    Robinson, Thompson
    Arima, Hisatomi.
    Broderick, Joseph
    Demchuk, Andrew
    Donnan, Geoffrey
    Kim, Jong
    Lavados, Pablo
    Lee, Tsong Hai
    Lindley, Richard
    Martins, Sheila
    Pandian, Jeyaraj
    Chalmers, John
    Anderson, Craig
    STROKE, 2017, 48
  • [23] Low-dose vs. standard-dose intravenous alteplase for acute ischemic stroke with unknown time of onset
    Wang, Zekun
    Ji, Kangxiang
    Fang, Qi
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [24] "False ischaemic penumbra" complicates decision making in acute stroke thrombolysis
    de Souza, Aaron
    NEUROLOGY ASIA, 2021, 26 (02) : 435 - 437
  • [25] Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard?
    Dong, Yi
    Cao, Wenjie
    Cheng, Xin
    Fang, Kun
    Wu, Fei
    Yang, Lumeng
    Xie, Yanan
    Dong, Qiang
    STROKE AND VASCULAR NEUROLOGY, 2016, 1 (03) : 115 - 121
  • [26] Low-dose versus standard-dose alteplase in acute ischemic stroke in Asian stroke registries: an individual patient data pooling study (vol 14, pg 670, 2019)
    Wang, X.
    Li, J.
    Moullaali, T. J.
    Lee, K. J.
    Kim, B. J.
    Bae, H. J.
    Wang, A.
    Wang, Y.
    Wang, D. Z.
    Wang, Y.
    Kumamoto, M.
    Toyoda, K.
    Koga, M.
    Sato, S.
    Yoshimura, S.
    Sui, Y.
    Xu, B.
    Xiao, Y.
    Lee, T. H.
    Liou, C. W.
    Lee, J. D.
    Peng, T., I
    Huang, Y. C.
    Paliwal, P. R.
    Sharma, M.
    Escabillas, C.
    Navarro, J. C.
    Sun, M. C.
    Dong, Y.
    Dong, Q.
    Anderson, C. S.
    Sharma, V. K.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (09) : NP13 - NP13
  • [27] Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke
    Sandercock, P
    Counsell, C
    Stobbs, SL
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (02):
  • [28] Low-dose vs. standard-dose alteplase for Chinese patients with acute ischemic stroke: A propensity score analysis
    Xu, Jiawen
    Chen, Xi
    Xie, Yanan
    Wang, Yi
    Chen, Shidong
    Dong, Qiang
    Dong, Yi
    Fang, Kun
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [29] Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke
    Sandercock, Peter A. G.
    Counsell, Carl
    Tseng, Mei-Chiun
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (03):
  • [30] Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke
    Sandercock, Peter A. G.
    Leong, Tze Shin
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (04):
12345